Drug interactions
Dichlorphenamide + Empagliflozin-metformin
Severity: Major
Dichlorphenamide and Empagliflozin-metformin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dichlorphenamide, a carbonic anhydrase inhibitor, causes hyperchloremic metabolic acidosis. Metformin carries a risk of lactic acidosis, and SGLT2 inhibitors carry a risk of ketoacidosis, so the combined acid-base burden is a concern.
What this interaction means in plain words
Dichlorphenamide and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Dichlorphenamide belongs to Miscellaneous; Empagliflozin-metformin belongs to Endocrine.
Why it happens
Additive acidosis through bicarbonate loss from carbonic anhydrase inhibition and the acid-base effects of metformin and empagliflozin.
What to do
Monitor serum bicarbonate and electrolytes at baseline and periodically, and reassess therapy if metabolic acidosis develops or persists.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Empagliflozin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Empagliflozin-metformin
Other interactions of Dichlorphenamide
Frequently asked questions
Can I take Dichlorphenamide with Empagliflozin-metformin?
MediHelp rates the interaction as major. Dichlorphenamide and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dichlorphenamide, a carbonic anhydrase inhibitor, causes hyperchloremic metabolic acidosis. Metformin carries a risk of lactic acidosis, and SGLT2 inhibitors carry a risk of ketoacidosis, so the combined acid-base burden is a concern.
How serious is the interaction between Dichlorphenamide and Empagliflozin-metformin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum bicarbonate and electrolytes at baseline and periodically, and reassess therapy if metabolic acidosis develops or persists.
What other medicines interact with Empagliflozin-metformin?
MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
